Usability Study of PF-06410293, an Adalimumab Biosimilar, by Prefilled Pen: Open-Label, Single-Arm, Sub-Study of a Phase 3 Trial in Patients with Rheumatoid Arthritis.

Saved in:
Bibliographic Details
Title: Usability Study of PF-06410293, an Adalimumab Biosimilar, by Prefilled Pen: Open-Label, Single-Arm, Sub-Study of a Phase 3 Trial in Patients with Rheumatoid Arthritis.
Authors: Fleischmann, Roy M.1 (AUTHOR) rfleischmann@arthdocs.com, Bock, Amy E.2 (AUTHOR), Zhang, Wuyan3 (AUTHOR), Godfrey, Charles M.4 (AUTHOR), Vranic, Ivana5 (AUTHOR), Cronenberger, Carol6 (AUTHOR), Dokoupilová, Eva7,8 (AUTHOR)
Source: Rheumatology & Therapy. Jun2022, Vol. 9 Issue 3, p839-850. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21986576
DOI:10.1007/s40744-022-00439-8